Please ensure Javascript is enabled for purposes of website accessibility
홈 > 제품 > 항체 > 바이오시밀러

Anti-Human Neuropilin-1/NRP1 Reference Antibody (Vesencumab, RUO) (HT070016)

Anti-Human Neuropilin-1/NRP1 Reference Antibody (Vesencumab, RUO)
Anti-Human Neuropilin-1/NRP1 Reference Antibody (Vesencumab, RUO)
Anti-Human Neuropilin-1/NRP1 Reference Antibody (Vesencumab, RUO)
Anti-Human Neuropilin-1/NRP1 Reference Antibody (Vesencumab, RUO)
가격(USD):
사양:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
수량:
문의하기
  • 개요

  • 이미지

  • 참고 문헌

  • 데이터시트

  • SDS

개요
카탈로그 번호HT070016
설명
Vesencumab (HT070016) is a research-grade recombinant antibody targeting CD304. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
종 반응성Human
응용 분야ELISA, Bioactivity: FACS, Functional assay, Research in vivo
숙주 종Human
클론성Monoclonal
이소타입IgG1-kappa
발현 시스템 Mammalian cells
타겟 NRP1, Neuropilin-1, VEGF165R, NRP, CD304, Vascular endothelial cell growth factor 165 receptor
내독소 수준 < 10 EU/mg
순도 >95% purity as determined by SDS-PAGE.
정제 Protein A/G purified from cell culture supernatant.
등록번호 O14786
형태 Liquid
저장 완충액 0.01M PBS pH 7.4

데이터시트 인쇄본 또는 로트별 COA에 기재된 구체적인 완충액 정보를 참조하세요.

안정성 및 저장 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
대체 이름MNRP1685A, 1205533-60-3
배경

Neuropilin-1 (CD304/NRP1) is a ~103 kDa protein. Cell-surface receptor involved in the development of the cardiovascular system, in angiogenesis, in the formation of certain neuronal circuits and in organogenesis outside the nervous system. Mediates the chemorepulsant activity of semaphorins. Recognizes a C-end rule (CendR) motif R/KXXR/K on its ligands which causes cellular internalization and vascular leakage. It binds to semaphorin 3A, the PLGF-2 isoform of PGF, the VEGF165 isoform of VEGFA and VEGFB. Coexpression with KDR results in increased VEGF165 binding to KDR as well as increased chemotaxis.

1. Gagnon, ML. et al. (2000) Proceedings of the National Academy of Sciences of the United States of America 97, 2573-8. PMID: 10688880
2. He, Z. et al. (1997) Cell 90, 739-51. PMID: 9288753
3. Soker, S. et al. (1998) Cell 92, 735-45. PMID: 9529250
4. Teesalu, T. et al. (2009) Proceedings of the National Academy of Sciences of the United States of America 106, 16157-62. PMID: 19805273
5. Issitt, T. et al. (2019) iScience 11, 205-223. PMID: 30623799
참고사항 For research use only. Not suitable for clinical or therapeutic use.
Isotype Control Human IgG1 Recombinant Isotype Control Antibody (13R4) (HV080507)
이미지
  • Anti-Human Neuropilin-1/NRP1 Reference Antibody (Vesencumab, RUO)

    Bioactivity

    SEC-HPLC detection for Research Grade Vesencumab.

  • Anti-Human Neuropilin-1/NRP1 Reference Antibody (Vesencumab, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Vesencumab.

참고 문헌
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
추천

문의하기 맞춤형 견적, 대량 주문 및 기타 문의 사항은

메일: [email protected]

배급사 목록